Today is a good day for potheads, and a great one for the nation’s state-regulated marijuana businesses. In a historic move, the federal government will reclassify cannabis to a more lenient category.

Marijuana’s classification as one of the most dangerous and habit-forming substances has long drawn criticism. By Luke Broadwater and Ashley Southall Luke Broadwater reported from Washington, and ...

Germany's military has been rocked by reports of widespread sexual harassment and right-wing extremism in an elite paratroop ...

Brad Johnson's family surrounded him as the elevator rose toward his celebration. "We've just been waiting for this day for ...

Dangerous criminals are using San Francisco’s Drug Court program as a get-out-of-jail free card, a new data analysis shows — ...

Dec 19 (Reuters) - The U.S. government on Friday announced pilot programs to start in 2026 and 2027 that are aimed at reducing out-of-pocket drug costs under the Medicare healthcare program for older ...

The U.S. Food and Drug Administration (FDA) is preparing to fast-track reviews of two experimental Merck & Co. Inc. (NYSE: MRK) drugs with potential blockbuster sales. Merck's cholesterol treatment ...

SIMI VALLEY, CA - January 09, 2026 - PRESSADVANTAGE - All In Solutions California has reinforced its commitment to ...

Medicare drug price negotiations kick-started by the Biden administration will finally result in lower drug prices for seniors beginning Jan. 1. The Medicare-negotiated price cuts will apply to 10 ...

For the fifth consecutive year, the number of American teenagers using drugs and alcohol remains at a historic low. New survey data show that the dramatic decrease in substance use that began during ...

Daniel Payne reports on how the health industry and Washington influence and impact each other. He joined STAT in 2025 after covering health care at POLITICO. You can reach Daniel on Signal at danielp ...

Section 1. Purpose and Policy. Americans deserve access to the best medical treatments and research infrastructure in the world. In 2023, the Food and Drug Administration (FDA) completed a review of ...